The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

VERTEX PHARMACEUTICALS INC / MA insider acquisitions

Company CIK 0000875320 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
VRTX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
90-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Stock awardCode ADeferred Stock UnitsDerivative · Currency not specified2Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.SACHS BRUCE ISACHS BRUCE IGarber Alan MGarber Alan MLEIDEN JEFFREY MLEIDEN JEFFREY MUpadhyay SuketuUpadhyay SuketuSACHS BRUCE I · October 15, 2026 · Stock award · Deferred Stock UnitsGarber Alan M · October 15, 2026 · Stock award · Deferred Stock UnitsLEIDEN JEFFREY M · December 4, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · December 3, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · November 14, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · November 14, 2025 · Exercise / conversion · Common StockLEIDEN JEFFREY M · November 13, 2025 · Exercise / conversion · Common StockUpadhyay Suketu · October 15, 2025 · Stock award · Deferred Stock UnitsSACHS BRUCE I · October 15, 2025 · Stock award · Deferred Stock UnitsOct 15, 2025Oct 15, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 15, 2026VERTEX PHARMACEUTICALS INC / MADeferred Stock UnitsSACHS BRUCE IStock award
Oct 15, 2026VERTEX PHARMACEUTICALS INC / MADeferred Stock UnitsGarber Alan MStock award
Dec 4, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Dec 3, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Nov 14, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Nov 14, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Nov 13, 2025VERTEX PHARMACEUTICALS INC / MACommon StockLEIDEN JEFFREY MExercise / conversion
Oct 15, 2025VERTEX PHARMACEUTICALS INC / MADeferred Stock UnitsUpadhyay SuketuStock award
Oct 15, 2025VERTEX PHARMACEUTICALS INC / MADeferred Stock UnitsSACHS BRUCE IStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

VRTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Stock awardDeferred Stock UnitsDerivative security · Code A92.694512.44Value: 47,500.11336Currency not specifiedView ↗
Trade: Stock awardDeferred Stock UnitsDerivative security · Code A29.272512.44Value: 15,000.14368Currency not specifiedView ↗
Trade:
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M191.05Value: 91.05Currency not specifiedView ↗
Trade:
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M63,78186.52Value: 5,518,332.12Currency not specifiedView ↗
Trade:
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M39,76986.52Value: 3,440,813.88Currency not specifiedView ↗
Trade:
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M13,83591.05Value: 1,259,676.75Currency not specifiedView ↗
Trade:
LEIDEN JEFFREY MExecutive Chairman · Director
Exercise / conversionCommon StockNon-derivative security · Code M19,68891.05Value: 1,792,592.4Currency not specifiedView ↗
Trade: Stock awardDeferred Stock UnitsDerivative security · Code A86.825410.31Value: 35,625.16575Currency not specifiedView ↗
Trade: Stock awardDeferred Stock UnitsDerivative security · Code A115.766410.31Value: 47,499.94746Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →